Iceland· IS-EU/1/01/197/003-005
Foscan
A temoporfin product containing temoporfinum inn, registered in Iceland by Biolitec Pharma Ltd.. The same ATC class is registered in 8 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Temoporfin is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XD05 (temoporfin), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 5 of them publish a price we can compare per daily dose
Temoporfin · ATC L01XD05
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Temoporfinum INN
- Manufacturer
- Biolitec Pharma Ltd.
- Country
- Iceland (IS)
- ATC code
- L01XD05
- ATC class
- Temoporfin
- Defined daily dose
- 10.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Temoporfin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumFoscan 1 mg/mlBiolitec Pharma
- CzechiaFOSCANbiolitec Pharma Ltd., Jena
- SpainFOSCAN 1 mg/ml SOLUCION INYECTABLEBiolitec Pharma Limited
- PolandFoscanbiolitec Pharma Ltd.
- SwedenFoscan 1 mg/ml Injektionsvätska, lösningBiolitec Pharma Ltd
- United KingdomFoscan 1mg/1ml solution for injection vialsBiolitec Pharma Ltd
- FinlandFoscanbiolitec Pharma Ltd.
- NetherlandsFoscan 1 mg/ml, oplossing voor injectieBiolitec Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6ca1645c-227b-4ea4-9b24-fdb0558ea5dc GET /v1/drugs/6ca1645c-227b-4ea4-9b24-fdb0558ea5dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "L01XD05",
"marketed": false,
"strength": "1 mg/ml",
"ma_number": "EU/1/01/197/003-005",
"substance": "Temoporfinum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "39398"
}See everything about temoporfin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.